sorry, we can't preview this file
pmed.1003588.s003.docx (46.74 kB)
Type-specific human papillomavirus (HPV) seroprevalence (%) among unvaccinated females under the age of 23 years by vaccination strategy—gender-neutral vaccination (Arm A), girls-only vaccination (Arm B), and control vaccination (Arm C)—and time period of sample donation (pre-vaccination era, 2005–2010, and post-vaccination era, 2011–2016).
journal contribution
posted on 2021-06-07, 17:29 authored by Penelope Gray, Hanna Kann, Ville N. Pimenoff, Tiina Eriksson, Tapio Luostarinen, Simopekka Vänskä, Heljä-Marja Surcel, Helena Faust, Joakim Dillner, Matti Lehtinen(DOCX)
History
Usage metrics
Categories
Keywords
gender-neutral vaccination armvaccination coverage levelsHPV type 16girls-only vaccination programsHuman papillomavirus seroprevalenceHPV 18 seroprevalence reductionHPV 16herd effectgirls-only vaccination strategiesPossible outcome misclassificationTrial registration ClinicalTrials.g...CIgender-neutral vaccination strategyvaccination coverageherpes simplex virus type 2 seropos...Arm Cgender-neutral HPV vaccinationPR 16cluster randomized trial Background...pre-vaccination-era HPV seroprevale...
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC